What is this ingredient? Amla (Phyllanthus emblica), also known as Indian gooseberry, is a small, sour fruit traditionally used in Ayurvedic medicine. It is exceptionally rich in vitamin C and hydrolysable tannins (such as emblicanin A and B), which confer strong antioxidant properties [0,2,3]. Standardized amla extracts have been evaluated in multiple human trials for effects on cardiovascular risk factors, oxidative stress, and metabolic health. In adults with dyslipidemia or metabolic syndrome, 12 weeks of amla extract supplementation significantly lowered total cholesterol, LDL‑cholesterol, triglycerides, and high‑sensitivity C‑reactive protein, while improving HDL‑cholesterol and atherogenic indices compared with placebo [0,1,2,8,9].
Amla has also shown benefits for endothelial function and oxidative stress markers. In patients with metabolic syndrome or type 2 diabetes, standardized amla extract improved reactive hyperemia index (a measure of endothelial function) and increased antioxidant biomarkers such as nitric oxide and glutathione while reducing malondialdehyde and hs‑CRP [6,8]. In uremic patients, 4 months of amla supplementation reduced 8‑iso‑prostaglandin and increased total antioxidant status, indicating a systemic reduction in oxidative stress [3].
Why include it in this formula? The NATTOKINASE 18‑IN‑1 POTENT BLEND combines vitamin C, vitamin B6, calcium, magnesium, nattokinase, lumbrokinase, serrapeptase, turmeric, botanical proteases, Japanese pagoda rutin, amla, CoQ10, and black pepper, clearly targeting circulatory health, fibrinolytic balance, and vascular comfort. Within that architecture, amla fruit extract is a key "polyphenol and antioxidant cardiometabolic" pillar. Its clinically demonstrated ability to improve endothelial function, lower atherogenic lipids, and reduce hs‑CRP and oxidative‑stress markers [1,2,3,6,8,9] directly supports healthier vessel walls and blood chemistry.
These actions complement nattokinase and lumbrokinase, which focus on fibrin and clot dynamics, and turmeric, rutin, vitamin C, and CoQ10, which support additional anti‑inflammatory and antioxidant pathways. By providing a concentrated, human‑studied botanical that addresses lipids, oxidative stress, and endothelial health at once, amla helps ensure the formula is not only working on the mechanical aspects of blood flow, but also on the underlying biochemical terrain that influences long‑term vascular resilience.
References
- [1] A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
- [2] Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study
- [3] Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients
- [6] Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
- [8] Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class‑1 obese adults